BioAge Labs, Inc. (BIOA) Form 10-K Annual Reports
BioAge Labs, Inc. (BIOA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BIOA
CIK: 1709941
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJason Trimborn
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-02 | 2026-10-02 | 8-K | 0001193125-26-412300 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003686 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-335407 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335368 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | 4 Filing | 0001836297-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001959173-26-004979 | View SEC Doc Filr Page |
| 144 | 2026-06-29 | — | 144 Filing | 0001959173-26-004955 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001840663-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001771213-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001245624-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001253886-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001573785-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | 4 Filing | 0001184175-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | 8-K | 0001193125-26-268518 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-226770 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002218 | View SEC Doc Filr Page |
| 8-K | 2026-05-08 | 2026-05-08 | 8-K | 0001193125-26-213472 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001193125-26-213466 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-27 | — | SCHEDULE 13G Filing | 0002012383-26-001675 | View SEC Doc Filr Page |
| 4 | 2026-04-24 | 2026-04-23 | 4 Filing | 0001120478-26-000013 | View SEC Doc Filr Page |
| ARS | 2026-04-21 | 2025-12-31 | ARS | 0001193125-26-166933 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-21 | — | DEFA14A | 0001193125-26-166751 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-21 | 2026-06-10 | DEF 14A | 0001193125-26-166738 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-01 | 4 Filing | 0001210905-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-04-01 | — | 144 Filing | 0001959173-26-002686 | View SEC Doc Filr Page |